Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Schnell

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Trials|September 1, 2023
Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preliminary baseline dataKristen Lantis, Patrick Schnell, Courtney R Bland, et al.
Breast Cancer Research : BCR|March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studiesJohannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Nature Materials|April 20, 2021
Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splittingDaniel A Grave, David S Ellis, Yifat Piekner, et al.
Nature Materials|September 10, 2021
Author Correction: Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splittingDaniel A Grave, David S Ellis, Yifat Piekner, et al.
The Oncologist|June 21, 2019
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 TrialVéronique Diéras, Nadia Harbeck, Anil Abraham Joy, et al.
Clinical and Translational Science|April 26, 2025
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based ApproachAhsan Rizwan, Hugh Giovinazzo, Tian Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2015
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensusFederico Cappuzzo, Denis Moro-Sibilot, Oliver Gautschi, et al.
The American Journal of Hospice & Palliative Care|August 24, 2021
Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in HospiceLaura C Prater, Brian O'Rourke, Patrick Schnell, et al.
Microsystems & Nanoengineering|September 27, 2021
Wafer-scale transfer route for top-down III-nitride nanowire LED arrays based on the femtosecond laser lift-off techniqueNursidik Yulianto, Andam Deatama Refino, Alina Syring, et al.
Clinical and Translational Science|April 26, 2025
Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial ImpactTian Yu, Chi-Yuan Wu, Srikumar Sahasranaman, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Trials|September 1, 2023
Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preliminary baseline dataKristen Lantis, Patrick Schnell, Courtney R Bland, et al.
Breast Cancer Research : BCR|March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studiesJohannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Nature Materials|April 20, 2021
Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splittingDaniel A Grave, David S Ellis, Yifat Piekner, et al.
Nature Materials|September 10, 2021
Author Correction: Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splittingDaniel A Grave, David S Ellis, Yifat Piekner, et al.
The Oncologist|June 21, 2019
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 TrialVéronique Diéras, Nadia Harbeck, Anil Abraham Joy, et al.
Clinical and Translational Science|April 26, 2025
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based ApproachAhsan Rizwan, Hugh Giovinazzo, Tian Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2015
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensusFederico Cappuzzo, Denis Moro-Sibilot, Oliver Gautschi, et al.
The American Journal of Hospice & Palliative Care|August 24, 2021
Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in HospiceLaura C Prater, Brian O'Rourke, Patrick Schnell, et al.
Microsystems & Nanoengineering|September 27, 2021
Wafer-scale transfer route for top-down III-nitride nanowire LED arrays based on the femtosecond laser lift-off techniqueNursidik Yulianto, Andam Deatama Refino, Alina Syring, et al.
Clinical and Translational Science|April 26, 2025
Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial ImpactTian Yu, Chi-Yuan Wu, Srikumar Sahasranaman, et al.
Pageof 4